The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new AI technology.

"And we're not used to having somebody without a career at stake in the room at a senior level," said Hudson.

A team of scientists at the University of Toronto have successfully implemented AI tools to speed up the process of ...

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.

The successful and safe delivery of therapeutics relies on understanding how easily drugs can pass through biological barriers which protect cells.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...